AFJK Market Analysis
Overview
Price chart · mood · technical indicatorsFundamentals
Updated daily after market closeValuation
- Forward P/E
- —
- PEG ratio
- —
- P/B
- 13.31
- P/S (TTM)
- —
- EV/EBITDA
- —
Profitability & growth
- ROE (TTM)
- 0.0%
- Operating margin
- 0.0%
- Revenue growth YoY
- 0.0%
- Dividend yield
- —
- Beta
- 0.23
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
News & Sentiment
50 articles · sorted by dateVia 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
About Aimei Health Technology Co., Ltd Ordinary Share
Company profileAimei Health Technology Co., Ltd. (AFJK) is at the forefront of transforming the healthcare landscape through its innovative digital platforms and state-of-the-art medical devices. The company specializes in telehealth and personalized medicine, utilizing advanced artificial intelligence and data analytics to improve patient outcomes and optimize healthcare delivery. With a strong focus on operational efficiency and a commitment to continuous innovation, Aimei is strategically positioned for significant growth in the rapidly evolving healthcare sector, making it an attractive opportunity for…
Classification
- Sector
- Financial Services
- Industry
- Shell Companies
- Exchange
- NASDAQ
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 10 EAST 53RD STREET, NEW YORK, NY
- Fiscal year end
- December
- Latest quarter
- Mar 31, 2026
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
